Skip to main content
Year archive

MAXCYTE, INC. — 2021 filings

All 115 regulatory filings released by MAXCYTE, INC. (MXCT) in 2021, sourced directly from the official regulator.

115 Filings
2021 Period
2021 filings (115)
Filing Released Lang
Holdings in Company
Major Shareholding Notification
2021-12-29 English
Total Voting Rights
Share Issue/Capital Change
2021-12-01 English
FORM 4 SUBMISSION
Director's Dealing
2021-11-23 English
Purchase of Common Stock
Director's Dealing
2021-11-23 English
Exercise of options and PDMR Dealing
Director's Dealing
2021-11-17 English
FORM 4 SUBMISSION
Director's Dealing
2021-11-16 English
FORM 4 SUBMISSION
Director's Dealing
2021-11-16 English
FORM 4 SUBMISSION
Director's Dealing
2021-11-16 English
FORM 4 SUBMISSION
Director's Dealing
2021-11-16 English
FORM 4 SUBMISSION
Director's Dealing
2021-11-16 English
MaxCyte Reports Third Quarter Financial Results
Earnings Release Q3 2021
2021-11-11 English
10-Q
Interim / Quarterly Report Q3 2021
2021-11-10 English
FORM 8-K
Regulatory Filings
2021-11-10 English
Appointment of Chairman of the Board
Board/Management Information
2021-11-03 English
FORM 8-K
Regulatory Filings
2021-11-02 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2021-10-29 English
License with Nkarta, Inc.
Regulatory Filings
2021-10-28 English
Notice of Results
Report Publication Announcement
2021-10-26 English
Holdings in Company
Major Shareholding Notification
2021-10-06 English
Notice of AGM and Change of Director
AGM Information
2021-10-01 English
Total Voting Rights
Regulatory Filings
2021-10-01 English
FORM 8-K
Regulatory Filings
2021-10-01 English
DEF 14A
Proxy Solicitation & Information Statement
2021-10-01 English
FORM 8-K
Regulatory Filings
2021-09-17 English
MaxCyte Set to Join Russell 2000® Index
Regulatory Filings
2021-09-17 English
Half-year Report
Earnings Release H1 2021
2021-09-14 English
Filing of Form 10-Q
Annual Report Q2 2021
2021-09-14 English
10-Q
Interim / Quarterly Report Q2 2021
2021-09-13 English
Issue of Equity and Total Voting Rights
Regulatory Filings
2021-09-06 English
Notice of Results
Report Publication Announcement
2021-09-02 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-11 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-11 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-11 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-11 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-11 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-11 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-11 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-11 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-11 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-11 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-11 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-11 English
FORM 4 SUBMISSION
Director's Dealing
2021-08-11 English
Grant of Options
Director's Dealing
2021-08-10 English
License with Sana Biotechnology
Regulatory Filings
2021-08-09 English
S-8
Registration Form
2021-08-05 English
Amendments to Bylaws
Regulatory Filings
2021-08-05 English
FORM 8-K
Regulatory Filings
2021-08-04 English
Director's Dealing 2021
Director's Dealing
2021-08-03 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-08-03 English
Closing of Offering
Capital/Financing Update
2021-08-03 English
Full Exercise of Over-Allotment Option
Capital/Financing Update
2021-08-02 English
424B4
Prospectus
2021-07-30 English
Second Price Monitoring Extn
Regulatory Filings
2021-07-30 English
Price Monitoring Extension
Regulatory Filings
2021-07-30 English
Director's Dealing 2021
Director's Dealing
2021-07-30 English
Pricing of Offering and Approval to List on Nasdaq
Capital/Financing Update
2021-07-30 English
Regulatory Filings 2021
Regulatory Filings
2021-07-30 English
S-1MEF
Regulatory Filings
2021-07-29 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-29 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-29 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-29 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-29 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-29 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-29 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-29 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-29 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-29 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-29 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-29 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-29 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-29 English
Regulatory Filings 2021
Regulatory Filings
2021-07-29 English
Regulatory Filings 2021
Regulatory Filings
2021-07-27 English
Regulatory Filings 2021
Regulatory Filings
2021-07-27 English
8-A12B
Regulatory Filings
2021-07-26 English
Launch of Offering and Application to List
Capital/Financing Update
2021-07-26 English
S-1/A
Registration Form
2021-07-26 English
Termination of DI facility and transition to CDI
Regulatory Filings
2021-07-19 English
S-1 Financial information & Directorate Change
Regulatory Filings
2021-07-12 English
Public Filing of Registration Statement with SEC
Capital/Financing Update
2021-07-12 English
Regulatory Filings 2021
Regulatory Filings
2021-07-09 English
S-1
Registration Form
2021-07-09 English
Regulatory Filings 2021
Regulatory Filings
2021-07-08 English
Result of Special Meeting
Regulatory Filings
2021-07-06 English
Regulatory Filings 2021
Regulatory Filings
2021-06-25 English
Regulatory Filings 2021
Regulatory Filings
2021-06-25 English
Publication of Annual Report and Accounts
Report Publication Announcement
2021-06-16 English
Stockholder Circular and Notice of Special Meeting
Regulatory Filings
2021-06-16 English
Maxcyte Appoints Two New Non-Executive Directors
Board/Management Information
2021-06-15 English
Regulatory Filings 2021
Regulatory Filings
2021-06-10 English
Total Voting Rights
Share Issue/Capital Change
2021-06-02 English
Signing of Strategic Platform Licence
Regulatory Filings
2021-05-25 English
Proposed Dual-Listing on Nasdaq
Regulatory Filings
2021-05-14 English
Regulatory Filings 2021
Regulatory Filings
2021-05-13 English
Consolidation of Trading Lines
Regulatory Filings
2021-05-13 English
Full Year Results
Earnings Release FY 2020
2021-04-20 English
Notice of Full Year Results
Report Publication Announcement
2021-04-15 English
Total Voting Rights
Regulatory Filings
2021-04-01 English
Holding(s) in Company
Major Shareholding Notification
2021-03-11 English
Total Voting Rights
Regulatory Filings
2021-03-03 English
Participation in Upcoming Investor Conferences
Regulatory Filings
2021-02-23 English
Director Dealings and Issue of Equity
Director's Dealing
2021-02-19 English
Grant of Options
Director's Dealing
2021-02-17 English
Holding(s) in Company
Major Shareholding Notification
2021-02-15 English
Holding(s) in Company
Major Shareholding Notification
2021-02-12 English
Holding(s) in Company
Major Shareholding Notification
2021-02-08 English
Price Monitoring Extension
Regulatory Filings
2021-02-05 English
Director Dealings and Issue of Equity
Director's Dealing
2021-02-04 English
CORRECTION: MaxCyte Announces £40m Subscription
Share Issue/Capital Change
2021-02-04 English
MaxCyte Announces £40 million Subscription
Capital/Financing Update
2021-02-03 English
Appointment of Joint Corporate Broker
Regulatory Filings
2021-02-03 English
Increase to Block Listing
Regulatory Filings
2021-01-21 English
Trading Update
Earnings Release FY 2020
2021-01-20 English
Myeloid Therapeutics Clinical & Commercial License
Regulatory Filings
2021-01-11 English